MiRNA-based therapies for the irritable bowel syndrome

Expert Opinion on Biological Therapy

Volumn 11, Issue 8, 2011, Pages 991-995

  Zhou, Qiqi ^a,b   Verne, G Nicholas ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

abdominal pain; diarrhea; inflammatory bowel disease; intestinal permeability; irritable bowel syndrome; microvesicle; miRNA

Indexed keywords

MICRORNA;

APOPTOSIS; BLOOD MICROVESICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VACUOLE; HUMAN; INTESTINE FUNCTION; IRRITABLE COLON; METABOLISM; REVIEW;

HUMANS; IRRITABLE BOWEL SYNDROME; MICRORNAS;

EID: 79959871196     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.577060     Document Type: Review

References (26)

1. Verne GN, Cerda JJ. Irritable bowel syndrome. Streamlining the diagnosis. Postgrad Med 1997;102:197-208
2. Verne GN, Robinson ME, Price DD. Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome. Pain 2001;93:7-14 (Pubitemid 32530837)
3. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11
4. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007;42(Suppl XVII):41-7 (Pubitemid 46140363)
5. Zhou Q, Zhang B, Verne GN. Intestinal membrane permeability and hyper-sensitivity in the irritable bowel syndrome. Pain 2009;146:41-6
6. Camilleri M, Nadeau A, Lamsam J, et al. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol exretion. Neurogastroenterol Motil 2010;22:e15-26
7. Al Chaer ED, Kawasaki M, Pasricha PJ. A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 2000;119:1276-85
8. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-48 (Pubitemid 34651445)
9. Zhou Q, Caudle RM, Price DD, Verne GN. Visceral and somatic hypersensitivity in a subset of rats following TNBS-Induced colitis. Pain 2008;134:9-15 (Pubitemid 350251000)
10. Ferrier L, Mazelin L, Cenac N, et al. Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice. Gastroenterology 2003;12:795-804 (Pubitemid 37070697)
11. Ait-Belgnaoui A, Bradesi S, Fioramonti J, et al. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kiase. Pain 2005;113:141-7 (Pubitemid 40038455)
12. Ait-Belgnaoui A, Han W, Lamine F, et al. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction. Neurogastroenterol Gut 2006;55:1090-4 (Pubitemid 44085673)
13. Zhou Q, Souba WW, Croce C, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2010;59:775-84
14. Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2alpha. Gastroenterology 2008;135:1624-35
15. Kapeller J, Houghton LA, Monnikes H, et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008;17:2967-77
16. Kim J, Krichevsky A, Grad Y, et al. Identification of many microRNAs that copurify with polyribomes in mammalian neurons. Proc Natl Acad Sci USA 2004;101:360-5 (Pubitemid 38084255)
17. Farh KK, Grimson A, Jan C, et al. The widespread impact of mammalian microRNA on mRNA repression and evolution. Science 2005;310:1817-21 (Pubitemid 41814382)
18. Garson R, Marcucci G, Croce CM. Targeting micRNAs in cancer: rationale, strategies, and challenges. Nat Rev 2010;9:775-89
19. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltranferases 3A and 3B. Proc Natl Acad Sci USA 2007;104:15805-10 (Pubitemid 350035380)
20. Tang Y, Banan A, Forsyth CB, et al. Effect of alcohol on miR-212 expressionin intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 2008;32:355-64
21. Biton M, Levin A, Slyper M, et al. Epithelial microRNA regulate gut mucosal immunity via epithelium-T cell cretalk. Nat Immunol 2011;12:239-47
22. Vicario M, Martinez C, Santos J. Role of microRNA in IBS with increased ghut permeability. Gut 2010;59:710-12
23. Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNA and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9 (Pubitemid 47214727)
24. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004;16:415-21 (Pubitemid 38903148)
25. Geijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: micrivesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999;94(11):3791-9
26. Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects, and challenges. Adv Drug Deliv Rev 2007;59:75-86. (Pubitemid 46770900)